Go to Article
Excerpt from readwrite.com
Neuralink announced last week that the tiny wires inside the brain of its first patient had retracted, but sources say they had known about this issue for years.
According to Reuters, the Elon Musk-founded company knew from animal testing that the wires could pull out of position, removing with them the sensitive electrodes that decode brain signals. Sources told Reuters the risk was deemed low enough for a redesign not to be merited.
Neuralink is an American neurotechnology company currently testing its brain implant in a person with quadriplegia with the hope they’ll be able to use digital devices by thinking alone.
On May 8, an update was provided as Noland Arbaugh, the study participant, had reached over 100 days since he received the Neuralink implant.
About The Author
